AzTrials
AzTrials

Bipolar DepressionEPIDEPNCT00757328

Treatment Clinical Practice in Bipolar Depression in Spain

An observational study of Bipolar Depression, run by AstraZeneca at 23 sites in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cross-sectional observational, non interventional, multicenter study of retrospective review of clinical records of ambulatory followed up bipolar patients in order to record epidemiological aspects of the course of the disorder, more specifically of bipolar depression episodes and the clinical practices carried out… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Bipolar Depression
How many people
378 participants
Where
23 sitesSpain
Study dates
Jul 2008to Dec 2008
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult bipolar I or II patients with no more than 10 years of evolution of the bipolar disorder, with continued assistance in ambulatory settings and whose psychiatrist has recorded the treatment strategy used for of at least 2 depressive episodes within the patients' bipolar condition in the clinical history

Who may be able to join

  • Diagnosed of Bipolar Disorder I or II (DSM-IV-TR) in ambulatory follow-up
  • Evolution of the bipolar diagnoses inferior to 10 years
  • Having recorded in the patient's clinical history the clinical management of at least two bipolar depressive episodes

Who cannot join

  • Not having enough information recorded in the clinical history for the essential measurement variables
  • To have taken part in other study in the last 6 months

Trial locations and contacts

23 sites in 1 country.

23 sites in 1 country

Spain23 sites
  • Research Site

    Alicante

  • Research Site

    Almería

  • Research Site

    Badajoz

  • Research Site

    Barcelona

  • Research Site

    Bilbao, Vizcaya

  • Research Site

    Cadiz

  • Research Site

    Córdoba

  • Research Site

    Donostia / San Sebastian, Guipuzcoa

  • Research Site

    Granada

  • Research Site

    Huesca

  • Research Site

    Las Palmas

  • Research Site

    León

  • Research Site

    Madrid

  • Research Site

    Málaga

  • Research Site

    Murcia

  • Research Site

    Oviedo, Principality of Asturias

  • Research Site

    Palma M, Mallorca

  • Research Site

    Pamplona, Navarre

  • Research Site

    Santander, Cantabria

  • Research Site

    Santiago C., La Coruna

  • Research Site

    Seville

  • Research Site

    Valencia

  • Research Site

    Valladolid

Other trials in Spain

About this study

Official title: EPIDEP. Epidemiologic Study in Bipolar Depression: Evaluation of the Usual Clinical Practice of Psychiatrists in Spain

Cross-sectional observational, non interventional, multicenter study of retrospective review of clinical records of ambulatory followed up bipolar patients in order to record epidemiological aspects of the course of the disorder, more specifically of bipolar depression episodes and the clinical practices carried out by psychiatrists in Spain in bipolar depressive episodes

Keywords
Bipolar depression Treatment
Medical subject headings
Bipolar Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00757328
Study groupRoleWhat they receive
1Ambulatory bipolar I and II patients, clinically stabilized for at least the two months prior to recruitment and who had at least one acute episode (depressive, manic, hypomanic or mixed) within the year prior to recruitment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pharmacological treatments used in Spain by Psychiatrists in the management of bipolar depressive episodes in first and second line

    Measured: Last two bipolar episodes recorded in tha patient's clinical history

Secondary outcomes (2)
  1. Non pharmacological treatments used in Spain by Psychiatrists in the management of bipolar depressive episodes in first and second line

    Measured: Last two bipolar episodes recorded in tha patient's clinical history

  2. Description of the course of the patients' bipolar disorder

    Measured: Course of the disorder recorded in the patient's clinical history

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2008 (estimated)
  2. Study startJul 2008
  3. Study completionDec 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
378 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00757328
Sponsor's protocol ID
NIS-NES-DUM-2008/3
Acronym
EPIDEP
Status last verified
Feb 2009
First submitted
22 Sep 2008
Last updated
18 Feb 2009
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bipolar Depression, run by AstraZeneca at 23 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 23 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pharmacological treatments used in Spain by Psychiatrists in the management of bipolar depressive episodes in first and second line (time frame: Last two bipolar episodes recorded in tha patient's clinical history). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2009; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in